Important article published yesterday (January 4), RVX208 relevant
|
13
|
Resverlogix Corp.
|
Jan 05, 2019 07:34AM
|
Impact factors
|
8
|
Resverlogix Corp.
|
Apr 16, 2019 03:31AM
|
If anyone still cares about science...
|
9
|
Resverlogix Corp.
|
Oct 09, 2020 04:38PM
|
From abstract 6 days ago: BRD inhibitors are promising candidates to prevent COVID-19 mediated cardiac damage
|
6
|
Resverlogix Corp.
|
Oct 21, 2020 01:59PM
|
Exceptionally good news
|
14
|
Resverlogix Corp.
|
Nov 18, 2019 10:21AM
|
ESC Congress 2016
|
4
|
Resverlogix Corp.
|
Sep 05, 2016 02:33PM
|
Did you know...?
|
10
|
Resverlogix Corp.
|
Jul 05, 2017 04:33PM
|
Comments re AHA presentation
|
12
|
Resverlogix Corp.
|
Nov 16, 2019 06:32PM
|
Civil vs. criminal court judgments
|
9
|
Resverlogix Corp.
|
Dec 17, 2019 10:03AM
|
Chronic Kidney Disease and BET inhibition, event coming up
|
4
|
Resverlogix Corp.
|
Mar 28, 2017 03:31PM
|
BET bromodomain suppression inhibits vascular inflammation by blocking NF-κB and
|
6
|
Resverlogix Corp.
|
Oct 27, 2016 04:32PM
|
BD2 specific inhibitors mentioned in Science
|
9
|
Resverlogix Corp.
|
Mar 22, 2020 06:53AM
|
Apabetalone, a drug that reduces MACE in CKD patients
|
18
|
Resverlogix Corp.
|
Jun 05, 2020 05:03PM
|
All - I mean ALL - about the ASSURE trial
|
5
|
Resverlogix Corp.
|
Sep 15, 2017 03:19PM
|
Abstract - first example of a "curative" effect?
|
10
|
Resverlogix Corp.
|
Oct 10, 2018 05:28PM
|
ABBV-744 is BD2 specific - worth a read
|
10
|
Resverlogix Corp.
|
Feb 02, 2022 03:26PM
|
10BagR, part 2 - repost attempt number don't know what
|
1
|
Resverlogix Corp.
|
Nov 27, 2020 04:21PM
|
10BagR, part 1 - repost attempt number don't know what
|
2
|
Resverlogix Corp.
|
Nov 27, 2020 04:18PM
|